Search Results 31-40 of 16698 for HMB loading phase

  1. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Non-squamous NSCLC Without AGA - Mayo Clinic

    The purpose of this study is to measure efficacy and safety of Dato-DXd compared with docetaxel in participants with previously treated TROP2 QCS-NMR positive ...

  2. https://www.mayoclinic.org/chinese_procedure_concepts.xml

  3. Muscle and Adipose Trafficking of Fatty Acids Under Hypoinsulinemic and Fed Conditions - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  4. Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors - Mayo Clinic

    This study will also learn more about how the combination of these two investigational drugs may work for patients with certain cancers (specifically metastatic ...

  5. ACP Max Cellular Characterization At 90 ML Starting Volume - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  7. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    The purpose of the phase 2 portion is to estimate the PFS of patients with advanced soft tissue sarcoma by RECIST 1.1. Participation eligibility. Participant ...

  8. Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. A Phase 1 Study Of Anitocabtagene Autoleucel For The Treatment Of Subjects With Non-oncology Plasma Cell-related Diseases - Mayo Clinic

    A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia ...

  10. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... load within 6 months are eligible for this trial; ... loads within the past 6 ...